the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Ali Puteh fails in appeal to set aside sister-in-law’s suit

KUALA LUMPUR: Comedian Ali Puteh today failed in his appeal to set aside the decision of the Sessions Court regarding the RM60,000 in damages that must be paid to his sister-in-law Siti Nor Hidayah Mohd Ali for defaming her on social media, two years ago.

Lawyer Noorazmir Zakaria, who represented Ali Puteh, whose real name is Syed Ali Mubarak Syed Mohd Ridzuan, said High Court Judicial Commissioner Datuk Ahmad Shahrir Mohd Salleh rejected the comedian’s appeal with a cost of RM5,000.

In addition, Ahmad Shahrir also rejected the appeal of Siti Nor Hidayah, who is the widow of comedian Abam Bocey, to increase the amount of damages ordered by the Sessions Court.

“Syed Ali and three members of his family’s appeal to set aside the decision of the Sessions Court which dismissed their defamation suit against cosmetics entrepreneur Datuk Seri Aliff Syukri Kamarzaman and Siti Nor Hidayah was also rejected with the same cost (RM5,000),“ said the lawyer when contacted after today’s proceedings conducted online.

Meanwhile, Noorazmir said he has not received further instructions from his client whether to appeal against today’s decision.

On Feb 18, the Sessions Court ruled in Siti Nor Hidayah’s favour over a suit she filed against her brother-in-law over a derogatory statement on his Instagram account on Feb 10, 2020.

On Aliff Syukri’s involvement, Judge Zulqarnain Hassan said the court was satisfied that the entrepreneur had no malicious intent to conspire with the deceased’s wife to defame the plaintiffs.

Siti Nor Hidayah filed the suit in May 2020 over statements made by Ali Puteh on his Instagram account, among others, describing the woman as an evil wife and greedy for her husband’s inheritance.-Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings